Interleukin 12 gene therapy (Regulon)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterleukin 12 gene therapy (Regulon)
Drug Alias Name白细胞介素12基因治疗LipoVIL-12
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionImmunomodulatorsGene transferenceInterleukin-12 stimulants
TargetsInterleukin-12
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRegulon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRegulon
Active IndicationsN/A
Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A
Related LinksN/A